Replies to post #198938 on Biotech Values

[DewDiligence]

Re: MNTA’s M923 (Humira FoB) & SHPG/BXLT merger

If SHPG passes on M923, they will still have to pay the program’s development costs for 12 months.

Moreover, if SHPG returns M923 to MNTA, M923 could end up being part of the MNTA-MYL collaboration, according to Craig Wheeler on today’s DB webcast.

[DewDiligence]

BXLT and SHPG shareholders approve merger:

http://finance.yahoo.com/news/baxalta-shareholders-vote-approve-combination-125900591.html

http://www.marketwatch.com/story/shire-shareholders-approve-32-bln-baxalta-merger-2016-05-27

[DewDiligence]

SHPG closes BXLT acquisition: #msg-123065519

http://finance.yahoo.com/news/shire-completes-combination-baxalta-creating-074000355.html

SHPG will keep (and possibly add to) BXLT’s newly opened R&D office in Cambridge, MA.

Elapsed time from BXLT creation (by spin-off from BAX) until buyout: 11 months, 2 days.